All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.

Our financial data in facts & figures

OUR REVENUES

EBITDA (2021)

75,5 (20,4% of turnover)

EBIT (2021)

53,8 (14,5% of turnover)

NET RESULT (2021)

36,4 (9,8% of turnover)

OUR FIGURES BY FOCUS AREA (€ Millions, 2021)

145,704972397088 € Millions

JOINT CARE

43,5174575427342 € Millions

SKIN CARE

72,0400280058411 € Millions

EYE CARE

4,47464872 € Millions

ACTIVE SUBSTANCES

28,5614007940102 € Millions

CORTICOSTEROIDS

76,883507540341 € Millions

OTHER

OUR FIGURES BY PRODUCT CATEGORY (€ Millions, 2021)

PRESCRIPTION DRUGS

MEDICAL DEVICES

VACCINES

OTHER

OUR FIGURES BY GEOGRAPHICAL AREA (€ Millions, 2021)

190,077123810019 € Millions

ITALY

88,7572507949103 € Millions

EUROPE

13,31175631 € Millions

MENA

53,5833368677323 € Millions

USA

25,4699832173382 € Millions

RoW

OUR GROUP

GOVERNANCE

Find out more